Elevage Medical Technologies announced that Elucid received $55 million in Series D financing to advance AI-powered cardiovascular imaging and bring more precise, personalized approaches to the diagnosis and treatment of cardiovascular disease.
Public source
Publisher name
Public post
Congratulations to Elucid on its $55 million Series D financing! We’re proud to support Kelly Huang, PhD and the Elucid team as they advance AI-powered cardiovascular im…
Company
Elevage Medical Technologies
Fueling Life-Changing Medical Technologies
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11–50 employees
About Elevage Medical Technologies
Elevage Medical Technologies is dedicated to supporting medical device companies that can meaningfully improve health outcomes and quality of life for patients. Through capital investment and strategic operational support, Elevage strives to accelerate the pace of innovation in the medical technology space. We provide capital and strategic support to growth-stage medtech companies to advance approval and commercialization. To learn more about Elevage, please visit www.elevagemedicaltechnologies.com
See moreDiscover more
Similar signals
Similar public activity from other companies.
Capital & Finance
Elucid
Elucid closed an oversubscribed $55 million Series D financing round bringing its total funding to approximately $185 million.
Capital & Finance
Concord Health Partners
Concord Health Partners is raising $90 million Series C funding through a partnership with Scan.com to expand its diagnostic imaging network.
Capital & Finance
YZR Capital
YZR Capital led Scan.com in a Series C funding round of $220 million to build the world's largest AI-enabled medical imaging network.
Capital & Finance
Indaco Venture Partners
Indaco Venture Partners portfolio company Pi-Cardia announced a strategic investment from Medtronic to accelerate innovation for complex TAVR procedures and expand access to its ShortCut™ technology.
Capital & Finance
InHealth Ventures